---
$id: https://graph.org.ai/products/commodity/51241219
$type: Product
source: UNSPSC
code: "51241219"
title: "Tazarotene"
class: "51241200"
classTitle: "Dermatologic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tazarotene

**UNSPSC Code**: 51241219
**Class**: [Dermatologic agents](Dermatologic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a retinoic acid agent with the molecular formula C21H21NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81BDR9Y8PS, chemically known as 3-pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2h-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester but generally known as tazarotene, which bears US NIH Compound Identifier 5381. European Medicines Agency schedules Tazarotene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10844MIG. The term TAZAROTENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules tazarotene in its Anatomical Therapeutic Chemical (ATC) Classification. TAZAROTENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tazarotene under HS 29349990 and SITC 51579. As of Q4 2014, TAZAROTENE remains the US FDA Preferred Term for this commodity. Tazarotene bears US NLM identifiers UMLS ID C0288792 and NCI Concept Code C29487. SMILES: S1CCC(C2C1CCC(C2)C#CC1NCC(CC1)C(=O)OCC)(C)C.

